Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: Cilnidipine: Cilnidipine 10 mg OD for one month
Control Intervention1: Amlodipine: Amlpdipine 5 mg for one month
Sponsors
Dr. Abhishek Kumar Singh
Eligibility
Inclusion criteria
Inclusion criteria: All Newly diagnosed essential hypertension (stage 1 or stage 2) attending the outpatient department, BRD Medical college, Gorakhpur No history of cardiovascular diseases or other comorbidities that might confound the study. Patients giving written informed consent will be taken
Exclusion criteria
Exclusion criteria: Secondary hypertension (e.g., renal, endocrine). Pregnancy or lactation. Known hypersensitivity to calcium channel blockers. Severe renal or hepatic dysfunction. Patients on other antihypertensive therapies. Not giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of lifeTimepoint: Reduction in systolic and diastolic blood pressure (SBP and DBP) measured at baseline, 1 month, 3 months, 6 months, 9 month, 12 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events (e.g., peripheral edema, dizziness, headache). Changes in heart rate. Patient compliance assessed via pill count or self-report Timepoint: At 1 month , 3 month , 6 month ,9 month ,12 month | — |
Countries
India
Contacts
Public ContactDr Abhishek Kumar Singh
BRD Medical College, Gorakhpur, UTTAR PRADESH.
Outcome results
None listed